Inflammatix + AWS: Point-of-care Precision Medicine using Transcriptomics and Machine Learning
Inflammatix + AWS: Point-of-care Precision Medicine using Transcriptomics and Machine Learning
|
Loading...
Lütfen bekleyiniz...
Type
Size

İlgili Videolar

Inflammatix + AWS: Point-of-care Precision Medicine using Transcriptomics and Machine Learning

Inflammatix + AWS: Point-of-care Precision Medicine using Transcriptomics and Machine Learning

|
Epigenomics and precision medicine

Epigenomics and precision medicine

|
Inflammatix: A New Approach to Diagnosing Sepsis: Host Response Profiling

Inflammatix: A New Approach to Diagnosing Sepsis: Host Response Profiling

|
Dr. Dan Peterson - Precision medicine and artificial intelligence

Dr. Dan Peterson - Precision medicine and artificial intelligence

|
Immune Profiling: A New Way to Diagnose Infections | Tim Sweeney, MD, PhD | TEDxPaloAltoSalon

Immune Profiling: A New Way to Diagnose Infections | Tim Sweeney, MD, PhD | TEDxPaloAltoSalon

|
Dr. Tim Sweeney, Inflammatix Co-Founder & CEO, on Non-Dilutive Funding & Success, at 17th NDFS

Dr. Tim Sweeney, Inflammatix Co-Founder & CEO, on Non-Dilutive Funding & Success, at 17th NDFS

|
Inflammatix - Overview

Inflammatix - Overview

|
Inflammatix: The Need for Actionable Results to Diagnose Acute Infections & Sepsis in the ED

Inflammatix: The Need for Actionable Results to Diagnose Acute Infections & Sepsis in the ED

|
Feature representation learning for rare disease transcriptomics

Feature representation learning for rare disease transcriptomics

|
Inflammatix-"Heterogeneity"&"Dirty Data"-blessings in disguise for accelerating clinical translation

Inflammatix-"Heterogeneity"&"Dirty Data"-blessings in disguise for accelerating clinical translation

|
What is RNA Sequencing for Breast Cancer Diagnosis?

What is RNA Sequencing for Breast Cancer Diagnosis?

|
Inflammatix: Statistical Aspects for a Novel Test to Distinguish Bacterial from Viral Infections

Inflammatix: Statistical Aspects for a Novel Test to Distinguish Bacterial from Viral Infections

|
Inflammatix: Assessing COVID-19 Severity in the ED-an Interview with Dr. Nathan Shapiro

Inflammatix: Assessing COVID-19 Severity in the ED-an Interview with Dr. Nathan Shapiro

|
Inflammatix: Leveraging the host response to predict severe respiratory failure in COVID-19

Inflammatix: Leveraging the host response to predict severe respiratory failure in COVID-19

|
Using transcriptomic profiling to stratify sepsis patients

Using transcriptomic profiling to stratify sepsis patients

|
Molecular profiling of autoimmune inflammatory disease for prediction of response to therapy

Molecular profiling of autoimmune inflammatory disease for prediction of response to therapy

|
Inflammatix: Antimicrobial Stewardship in the Emergency Department in the Era of COVID-19

Inflammatix: Antimicrobial Stewardship in the Emergency Department in the Era of COVID-19

|
Sanger Seminar - Stratifying sepsis patients through transcriptomic profiling - Dr Emma Davenport

Sanger Seminar - Stratifying sepsis patients through transcriptomic profiling - Dr Emma Davenport

|
Transcriptomics for personalized medicine by Prof. Dr. Greg Gibson

Transcriptomics for personalized medicine by Prof. Dr. Greg Gibson

|
Inflammatix: The COVID-19 Pandemic ED Impact: Before, During, and After

Inflammatix: The COVID-19 Pandemic ED Impact: Before, During, and After

|
Copyright. All rights reserved © 2025
Rosebank, Johannesburg, South Africa